Pyrojas is a biotechnology company developing immune therapies that deliver durable control of cancer. Backed by the National Cancer Institute, Bristol Myers Squibb, venture capital, and a world-class team of scientists, clinical oncologists, and immunologists — including Nobel Laureate Dr. James Allison — we're advancing a new era of precision immunotherapy.